DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Armstrong AJ. et al.
Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial.
Lancet Oncol 2016;
17: 378-388
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.